Quality of Life in Psoriasis: A Cross-Sectional Study from North India

Background: Psoriasis is a chronic inflammatory papulo-squamous disease characterized by multiple remissions and relapses. This study aimed to assess the impact of psoriasis on the quality of life of patients. Materials and Methods: A hospital-based, cross-sectional study was conducted enrolling 198...

Full description

Saved in:
Bibliographic Details
Main Authors: Khushboo Arora, Neirita Hazarika, Ranjeeta Kumari, Himanshu Chawla
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2024-01-01
Series:Indian Journal of Dermatology
Subjects:
Online Access:https://journals.lww.com/10.4103/ijd.ijd_144_23
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832593681475960832
author Khushboo Arora
Neirita Hazarika
Ranjeeta Kumari
Himanshu Chawla
author_facet Khushboo Arora
Neirita Hazarika
Ranjeeta Kumari
Himanshu Chawla
author_sort Khushboo Arora
collection DOAJ
description Background: Psoriasis is a chronic inflammatory papulo-squamous disease characterized by multiple remissions and relapses. This study aimed to assess the impact of psoriasis on the quality of life of patients. Materials and Methods: A hospital-based, cross-sectional study was conducted enrolling 198 adult patients of psoriasis. The STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) guidelines for observational studies were followed. Clinical severity of psoriasis was measured using Psoriasis Area Severity Index (PASI), and quality of life was measured by EuroQoL 5D (EQ-5D-5L, EQ-VAS) and Psoriasis Quality-Of-Life-12 (PQOL-12) Questionniares. Results: Of the 198 patients, 71.7% (n = 142/198) were males with a mean age of 41.65 ± 13.19 years. The mean PASI score was 12.46 ± 11.51, and the mean PQOL-12 score was 50.18 ± 23.36. Up to 22.7% (n = 45) cases had ‘severe’ and 6.1% (n = 12) cases has ‘very severe’ PQOL-12 scores. Statistically significant correlation (P < 0.05) was observed between PASI scores and almost all domains of EQ-5D-5L and PQOL-12. Conclusion: Psoriasis affects most psycho-social domains of a patient’s life. Coping with these QOL issues remains a challenge to the patients in everyday life. The goal of management of psoriasis therefore must include measures to improve quality of life along with long-lasting remittance of physical symptoms.
format Article
id doaj-art-55301ba0e09e4c87bfa3dea5ed88ef97
institution Kabale University
issn 0019-5154
1998-3611
language English
publishDate 2024-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Indian Journal of Dermatology
spelling doaj-art-55301ba0e09e4c87bfa3dea5ed88ef972025-01-20T10:32:43ZengWolters Kluwer Medknow PublicationsIndian Journal of Dermatology0019-51541998-36112024-01-01691384310.4103/ijd.ijd_144_23Quality of Life in Psoriasis: A Cross-Sectional Study from North IndiaKhushboo AroraNeirita HazarikaRanjeeta KumariHimanshu ChawlaBackground: Psoriasis is a chronic inflammatory papulo-squamous disease characterized by multiple remissions and relapses. This study aimed to assess the impact of psoriasis on the quality of life of patients. Materials and Methods: A hospital-based, cross-sectional study was conducted enrolling 198 adult patients of psoriasis. The STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) guidelines for observational studies were followed. Clinical severity of psoriasis was measured using Psoriasis Area Severity Index (PASI), and quality of life was measured by EuroQoL 5D (EQ-5D-5L, EQ-VAS) and Psoriasis Quality-Of-Life-12 (PQOL-12) Questionniares. Results: Of the 198 patients, 71.7% (n = 142/198) were males with a mean age of 41.65 ± 13.19 years. The mean PASI score was 12.46 ± 11.51, and the mean PQOL-12 score was 50.18 ± 23.36. Up to 22.7% (n = 45) cases had ‘severe’ and 6.1% (n = 12) cases has ‘very severe’ PQOL-12 scores. Statistically significant correlation (P < 0.05) was observed between PASI scores and almost all domains of EQ-5D-5L and PQOL-12. Conclusion: Psoriasis affects most psycho-social domains of a patient’s life. Coping with these QOL issues remains a challenge to the patients in everyday life. The goal of management of psoriasis therefore must include measures to improve quality of life along with long-lasting remittance of physical symptoms.https://journals.lww.com/10.4103/ijd.ijd_144_23pasipsoriasisqolquality of life
spellingShingle Khushboo Arora
Neirita Hazarika
Ranjeeta Kumari
Himanshu Chawla
Quality of Life in Psoriasis: A Cross-Sectional Study from North India
Indian Journal of Dermatology
pasi
psoriasis
qol
quality of life
title Quality of Life in Psoriasis: A Cross-Sectional Study from North India
title_full Quality of Life in Psoriasis: A Cross-Sectional Study from North India
title_fullStr Quality of Life in Psoriasis: A Cross-Sectional Study from North India
title_full_unstemmed Quality of Life in Psoriasis: A Cross-Sectional Study from North India
title_short Quality of Life in Psoriasis: A Cross-Sectional Study from North India
title_sort quality of life in psoriasis a cross sectional study from north india
topic pasi
psoriasis
qol
quality of life
url https://journals.lww.com/10.4103/ijd.ijd_144_23
work_keys_str_mv AT khushbooarora qualityoflifeinpsoriasisacrosssectionalstudyfromnorthindia
AT neiritahazarika qualityoflifeinpsoriasisacrosssectionalstudyfromnorthindia
AT ranjeetakumari qualityoflifeinpsoriasisacrosssectionalstudyfromnorthindia
AT himanshuchawla qualityoflifeinpsoriasisacrosssectionalstudyfromnorthindia